These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36376628)

  • 1. The Role of Physician Networks and Receipt of Opioid-Related Payments.
    Pope E; Sehgal N
    J Gen Intern Med; 2023 Jun; 38(8):1812-1820. PubMed ID: 36376628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' Payments.
    Winn AN; Mitchell AP; Fergestrom N; Neuner JM; Trogdon JG
    J Gen Intern Med; 2021 Jul; 36(7):1858-1866. PubMed ID: 33904046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical payments to physicians may increase prescribing for opioids.
    Nguyen TD; Bradford WD; Simon KI
    Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider-directed marketing may increase prescribing of medications for opioid use disorder.
    Nguyen T; Andraka-Christou B; Simon K; Bradford WD
    J Subst Abuse Treat; 2019 Sep; 104():104-115. PubMed ID: 31370974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
    Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
    J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty.
    Hollander MAG; Donohue JM; Stein BD; Krans EE; Jarlenski MP
    J Gen Intern Med; 2020 Aug; 35(8):2451-2458. PubMed ID: 31792860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.
    Hadland SE; Rivera-Aguirre A; Marshall BDL; Cerdá M
    JAMA Netw Open; 2019 Jan; 2(1):e186007. PubMed ID: 30657529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.
    Taylor SC; Huecker JB; Gordon MO; Vollman DE; Apte RS
    JAMA Ophthalmol; 2016 Aug; 134(8):897-903. PubMed ID: 27356110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of industry payments to psychiatrists and psychiatric advanced practice clinicians in the USA, 2021: a cross-sectional study.
    Havlik J; Ososanya L; Lee MS; Wahid S; Heyang M; Sun QW; Ross JS; Rhee TG
    BMJ Open; 2024 Feb; 14(2):e081252. PubMed ID: 38331855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies.
    Hollenbeck BK; Oerline M; Kaufman SR; Caram MEV; Dusetzina SB; Ryan AM; Shahinian VB
    Urology; 2021 Feb; 148():134-140. PubMed ID: 33075381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.
    Weng JK; Valle LF; Nam GE; Chu FI; Steinberg ML; Raldow AC
    JAMA Netw Open; 2019 Jan; 2(1):e187377. PubMed ID: 30681710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.
    Pham-Kanter G; Mello MM; Lehmann LS; Campbell EG; Carpenter D
    J Gen Intern Med; 2017 Jul; 32(7):767-774. PubMed ID: 28265803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between physician characteristics and payments from industry in 2015-2017: observational study.
    Inoue K; Blumenthal DM; Elashoff D; Tsugawa Y
    BMJ Open; 2019 Sep; 9(9):e031010. PubMed ID: 31542759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry Payments to Pain Medicine Physicians: An Analysis of the Centers for Medicare and Medicaid Services Open Payments Program.
    Goel V; Patwardhan AM; Ibrahim M; Yang Y; Sivanesan E; Banik RK; Shannon C; Shankar H
    Pain Med; 2021 Jun; 22(6):1376-1386. PubMed ID: 33765136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.
    Feng H; Wu P; Leger M
    JAMA Dermatol; 2016 Dec; 152(12):1307-1313. PubMed ID: 27706478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.